WEBINAR RECORDING AVAILABLE - WATCH ON DEMAND

Enhance your long-term cell & gene therapy success with pDNA manufacturing solutions

Critical starting materials such as plasmid DNA make a world of difference when it comes to cell and gene therapy, regenerative medicine and vaccine development.

In this webinar, we’ll explore:

How a manufacturing partner is critical to support long-term clinical success
Increasing the success of your program with manufacturing solutions to advance therapies forward
Maximizing new technology in research, discovery and preclinical applications

watch now

Matt Howard

Vice President, Manufacturing, Aldevron

Matt has more than 10 years’ experience in biotech and serves as VP of Manufacturing overseeing Global Research Grade Operations, Clinical RNA and Protein Manufacturing, and Manufacturing, Science and Technologies, with previous roles within Aldevron overseeing Clinical and Commercial Plasmid Manufacturing Operations. Prior to Aldevron, Matt worked in cell therapy manufacturing operations, supporting multiple clinical and commercially approved therapies as well as working in diagnostic immunoassay development.

Tyler Kozisek

Senior Scientist, R&D, Aldevron

Tyler received his bachelor’s degree in Mechanical Engineering and PhD in Biomedical Engineering from the University of Nebraska – Lincoln. His PhD work focused on enhancing nonviral gene delivery platforms for transfection of primary stem cells. Tyler joined Aldevron in March 2022 as an R&D Scientist, and is currently a Senior Scientist focused on designing, supporting, and advancing the Nanoplasmid® platform.

moderator

Arsalan Arif

Founder & publisher, endpoints news

Arsalan Arif is a news media entrepreneur who set out in 2015 to build his vision of an independent biotech news company at Endpoints News.